In patients with RA, there are changes in the (apolipoprotein B) ApoB: (apolipoprotein A-I) ApoA-I ratio, caused by the increase in ApoB levels (with pro-atherogenic properties) and the decrease in ApoA-I levels (with an anti-atherogenic profile). The gene discussed is APOB; the disease is rheumatoid arthritis.